
Background Nontuberculous mycobacterial (NTM) infections are increasingly recognized as triggers of antineutrophil cytoplasmic antibody (ANCA) positivity and secondary ANCA‐associated vasculitis. Differentiating infection‐associated ANCA disease from primary AAV is critical because management and outcomes differ. This case describes an uncommon organism triggering MPO‐ANCA glomerulonephritis and a management approach that avoided cytotoxic agents. Case Presentation A 57‐year‐old woman with chronic pulmonary disease presented with acute kidney injury, glomerular‐pattern (dysmorphic) microscopic hematuria, proteinuria, and MPO‐ANCA positivity. Kidney biopsy demonstrated pauci‐immune necrotizing and crescentic glomerulonephritis with marked chronicity (∼70% globally sclerosed glomeruli). Evaluation revealed pulmonary infection with multidrug‐resistant Mycobacterium abscessus complex. Given active infection, cyclophosphamide and rituximab were withheld. The patient received pulse intravenous methylprednisolone followed by oral prednisone with targeted antimicrobial therapy. Outcome Over approximately 6 months of follow‐up, serum creatinine improved from a peak of 3.9 mg/dL to 2.2 mg/dL and subsequently to 1.9 mg/dL, ESR and CRP normalized from peaks of 102 mm/h and 68 mg/L, hematuria resolved, and proteinuria decreased. Quantitative MPO‐ANCA, elevated at presentation, showed a progressive downtrend but remained detectable at last follow‐up. The renal course is best characterized as stabilization with partial improvement on a background of advanced chronic damage. Conclusion This case highlights M. abscessus as a rare trigger of infection‐associated MPO‐ANCA glomerulonephritis and demonstrates that antimicrobial therapy combined with corticosteroids, without cytotoxic agents, can achieve renal stabilization and partial improvement. A downtrending MPO‐ANCA titer, rather than a static one, is the serologic pattern most consistent with a resolving infection‐associated process. Recognition of infection‐driven ANCA disease is essential to avoid potentially harmful cytotoxic therapy during active infection.
Diffuse renal enlargement is an uncommon manifestation of lymphoma and may mimic primary renal disorders. We report a young woman who presented with acute kidney injury (AKI) and bilateral ballotable flank masses, initially suspected to represent polycystic kidney disease. Chest radiography demonstrated a large mediastinal mass, prompting cross-sectional imaging that revealed bulky anterior mediastinal disease with widespread nodal and extranodal involvement. Imaging showed asymmetric bilateral renal enlargement, markedly greater on the left, with diffuse hypodense infiltrative lesions radiologically suspicious for lymphomatous involvement. Core biopsy of the mediastinal mass confirmed primary mediastinal large B-cell lymphoma (PMBCL), and concurrent testing identified newly diagnosed human immunodeficiency virus infection. The patient developed anuric, dialysis-dependent AKI and died before definitive rituximab-based chemotherapy could be initiated. This case highlights an atypical and aggressive presentation of PMBCL with presumed diffuse renal involvement, emphasizing the need to consider infiltrative malignancy in patients with unexplained nephromegaly and AKI.
Introduction Myelodysplastic syndromes (MDS) may be overlooked in patients undergoing hemodialysis (HD) because anemia is commonly attributed to renal anemia and treated with erythropoiesis‐stimulating agents. MDS is also associated with an increased risk of bacterial infections due to neutropenia and qualitative immune dysfunction. We report recurrent invasive methicillin‐susceptible Staphylococcus aureus (MSSA) infections in a patient undergoing HD with concomitant MDS. Case Presentation The patient was a 76‐year‐old man undergoing HD for end‐stage kidney disease due to nephrosclerosis who was referred to our hospital because of persistent anemia despite high‐dose darbepoetin alfa therapy. He had a history of CHOP therapy for diffuse large B‐cell lymphoma, and his MDS was considered possibly therapy related. Bone marrow aspiration revealed trilineage dysplasia and 3.4% blasts without chromosomal abnormalities, leading to a diagnosis of MDS with multilineage dysplasia. Approximately 1 year later, he developed persistent fever. Blood cultures yielded MSSA, and imaging studies revealed septic pulmonary embolism and multiple cerebral infarctions. He improved after intravenous cefepime therapy. Twenty‐two months later, he developed fever and left shoulder pain. Contrast‐enhanced computed tomography revealed an abscess in the left subscapularis muscle, and MSSA was isolated from the drainage fluid after CT‐guided drainage. He improved with drainage and antibiotic therapy. In both episodes, the neutrophil count was preserved. Conclusion This case illustrates recurrent invasive MSSA infections in a non‐neutropenic HD patient with possibly therapy‐related MDS. HD‐related factors should be carefully evaluated as common causes of recurrent S. aureus infection, and MDS may represent an additional, unproven host factor. MDS should be considered in ESA‐resistant anemia in HD patients, particularly in those with a history of cytotoxic chemotherapy.
Background Clear cell renal cell carcinoma (ccRCC) is the most common histological subtype of malignant renal neoplasms, with an increasing incidence in Western countries. Early diagnosis is a critical determinant of prognosis, as advanced‐stage disease with metastatic dissemination entails a significantly reduced median survival. Characterizing complex cystic renal lesions presents a recognized diagnostic challenge on noncontrast computed tomography (CT), which often leads to underestimation and missed diagnoses. Artificial intelligence (AI) applied to diagnostic imaging is emerging as a supplementary decision‐support tool, but its integration must be critically evaluated to understand its potential to reduce diagnostic errors as well as its limitations. Case Presentation We report the case of a 73‐year‐old male physician with a history of myocardial infarction who presented with left flank pain. An initial noncontrast CT of the urinary tract on January 15 revealed a 37‐mm left upper‐pole renal cyst and a 5‐mm suspected calculus. The cyst was characterized as simple, and the report offered only a generic follow‐up recommendation. Over the next 4 months, the patient’s persistent pain was attributed entirely to presumed ureteric stone disease, leading to a ureteroscopy and ureteral stent placement, without characterizing the known renal cyst with contrast. On June 5 (5 months after the initial CT), a contrast‐enhanced CT revealed a 6‐cm heterogeneous, exophytic left renal mass. Subsequent staging confirmed pulmonary and cerebral metastases from ccRCC. The patient died in mid‐August, 7 months after the initial CT. Retrospective re‐evaluation of the baseline CT images, both by a senior radiologist and through an AI platform, confirmed that the lesion already exhibited features suspicious for neoplasia at the time of the first scan, warranting further investigation with contrast‐enhanced CT or magnetic resonance imaging in accordance with international guidelines. Simulated retrospective analysis via a web‐based AI platform not only flagged the mass as suspicious but also generated several critical errors (e.g., hallucinating contrast enhancement on the unenhanced scan, mislocalizing the mass to the mid‐to‐lower pole, and claiming it was “new” without comparison data). Conclusions This case demonstrates how a complex cystic renal lesion may be underestimated in the absence of contrast medium and an adequate level of clinical–radiological suspicion. Re‐evaluation by AI produced a result consistent with that of the expert radiologist, suggesting that systematic integration of AI tools into the radiological workflow could contribute to reducing diagnostic errors, particularly in settings where interobserver variability represents a clinically significant risk factor. AI can act as an effective supplementary decision‐support tool to reduce perceptual errors; clinicians and radiologists must remain highly vigilant regarding AI‐generated factual inconsistencies. Proper adherence to imaging guidelines and the use of contrast medium remain paramount.
Introduction Acute kidney injury (AKI) in the critical care unit is an independent risk factor for poor outcomes such as mortality. In patients with acute neurological injury and severe AKI, the timing and renal replacement therapy (RRT) modifications must be considered. Sustained low‐efficiency dialysis (SLED) is a cost‐effective alternative to continuous renal replacement therapy (CRRT) in critically ill AKI patients. We present a case of a 43‐year‐old male diagnosed with status epilepticus secondary to herpes simplex virus Type 1 (HSV‐1) central nervous system (CNS) infection who developed severe AKI and underwent SLED. Case Presentation We present a case of a 43‐year‐old male, hypertensive, with no known chronic kidney disease (CKD) who was referred to nephrology service for management of AKI. He was being managed as a case of status epilepticus secondary to CNS infection. Diagnostic tests revealed elevated creatinine at 3.72 mg/dL from 0.9 mg/dL. Blood urea nitrogen was at 39 mg/dL. Sodium was at 148 mEq/L, and potassium at 3.4 mEq/L. Urinalysis had trace protein, moderate blood, and red blood cells at 12 cells per high power field (hpf). Creatine kinase MM (CK‐MM) was at 514 U/L (2.2x ULN). The patient also had marginal urine output at 0.2–0.4 mL/kg/h with the patient weighing 86 kg. Although the patient had Stage 3 AKI, RRT was initiated as a supportive measure. He underwent SLED for 6 hours with net ultrafiltration at 0 mL. Urine output gradually improved from 0.9 to 1.3 mL/kg/h. Repeat creatinine taken 2 days after showed a decreasing trend to 2.68 mg/dL. Seizures were controlled with midazolam drip, valproic acid, and lacosamide. Renal parameters were continuously monitored, and continuation of renal replacement was not deemed necessary. During his stay at the neurocritical care unit, lumbar puncture was performed, and cerebrospinal fluid tested positive for HSV‐1. Appropriate antimicrobials and methylprednisolone pulse therapy 1 g intravenously for 5 days were given. Neurologic status improved with a Glasgow coma scale of 11T (E4VTM6). Renal parameters were serially monitored, with repeat creatinine prior to discharge at 0.6 mg/dL. Conclusion SLED can be used as a treatment modality in a neurocritically ill patient with status epilepticus for solute clearance. Good clinical judgment, early recognition, and ability to individualize care with management of AKI in the critical care unit can help improve clinical outcomes.